🌟 ABX Pearl of the Day: Optimizing duration of treatment for CAP 💊

🩺 A: While 2019 IDSA guidelines recommend 5 days, new data supports 3-day course of ABX for floor-status, immunocompetent patients with uncomplicated CAP who clinically respond within 3 days. #IDsky #MedSky #PharmSky 🔗for more info